Rosuvastatin is a member of the class of drugs known as "statins," which are used to lower cholesterol levels and reduce the risk of heart disease. Statins work by blocking an enzyme in the liver that helps produce cholesterol. Rosuvastatin is one of the most widely prescribed statins due to its potency and long-term safety profile. However, like all medications, rosuvastatin can interact with other medications, foods, and supplements. This review will explore the interactions of rosuvastatin and discuss the potential risks and benefits associated with its use.
Rosuvastatin can interact with other medications, foods, and supplements in a variety of ways. It can inhibit the absorption of certain medications, alter the metabolism of certain drugs, increase the risk of side effects, and even increase the risk of serious adverse reactions.
Rosuvastatin can interact with other medications, including some antibiotics, antifungals, and antiretrovirals. It can also interact with some drugs used to treat high blood pressure, depression, and other conditions. For example, rosuvastatin can reduce the effectiveness of certain antibiotics, such as erythromycin and clarithromycin, by reducing their absorption in the intestine. It can also reduce the effectiveness of antifungals, such as itraconazole and ketoconazole, by reducing their absorption. In addition, rosuvastatin can interact with drugs used to treat high blood pressure, such as ACE inhibitors and angiotensin receptor blockers, by increasing their effectiveness. It can also interact with certain drugs used to treat depression, such as selective serotonin reuptake inhibitors, by increasing their risk of side effects.
Rosuvastatin can also interact with certain foods and beverages. For example, grapefruit juice can increase the absorption of rosuvastatin, which can increase the risk of side effects. Alcohol can also increase the risk of side effects, so it is important to limit alcohol intake while taking rosuvastatin.
Finally, rosuvastatin can interact with certain dietary supplements. For example, red yeast rice, which is a dietary supplement derived from yeast, can interact with rosuvastatin and increase the risk of side effects.
The potential benefits and risks associated with taking rosuvastatin should be carefully considered before beginning treatment.
The primary benefit of taking rosuvastatin is that it can reduce cholesterol levels and reduce the risk of heart disease. In addition, rosuvastatin is generally well-tolerated and has a long-term safety profile.
The potential risks associated with taking rosuvastatin include an increased risk of side effects, such as muscle pain, weakness, or cramps, and an increased risk of serious adverse reactions, such as liver damage. In addition, rosuvastatin can interact with other medications, foods, and supplements, which can increase the risk of side effects or reduce the effectiveness of other drugs.
Rosuvastatin is a widely prescribed statin medication used to reduce cholesterol levels and reduce the risk of heart disease. However, like all medications, rosuvastatin can interact with other medications, foods, and supplements, which can increase the risk of side effects or reduce the effectiveness of other drugs. It is important to discuss the potential benefits and risks associated with taking rosuvastatin with a healthcare professional before beginning treatment.
1.
Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.
2.
Chronic pain and poor sleep are troublesome bed partners.
3.
In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.
4.
Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases?
5.
combating racial discrimination in next-generation breast cancer screening.
1.
Exploring the Use of Bevacizumab in Treating Different Types of Cancers
2.
A New Hope: How Procarbazine is Revolutionizing Cancer Treatment
3.
Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment
4.
Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part VI
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III
3.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
4.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
5.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation